Status:
COMPLETED
Trial to Compare eConsent With Standard Consent Among Prospective Biobank Participants
Lead Sponsor:
Geisinger Clinic
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Lynch Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this trial is to determine whether the Sage eConsent framework (presented using an electronic application) is non-inferior to traditional, paper-based, human-mediated consent-and therefore...
Detailed Description
The usual consent process for MyCode proceeds as follows: each day, trained MyCode consenters receive a list of patients who are eligible to be approached about MyCode and are scheduled to be seen tha...
Eligibility Criteria
Inclusion
- None
Exclusion
- None
Key Trial Info
Start Date :
November 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 19 2022
Estimated Enrollment :
703 Patients enrolled
Trial Details
Trial ID
NCT04131062
Start Date
November 1 2019
End Date
May 19 2022
Last Update
December 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geisinger
Danville, Pennsylvania, United States, 17821